Clin2
NCT07197853Possibly a fitNot yet recruiting

Microwave ablation plus herbal granules for early lung cancer

Non-small Cell Lung Cancer (NSCLC)Huaier GranulesMicrowave Ablation

Treatments studied

Part of Cancer, Lungs & breathing clinical trials.

This study tests whether combining microwave ablation (a procedure that uses heat to destroy cancer cells) with a herbal medicine called Huaier granules is safe and effective for people with early-stage lung cancer that cannot be removed with surgery. If you qualify, you may receive this combination to help control the cancer and improve your quality of life.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
180 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years of age or older.
  • You have been diagnosed with stage I-A non-small cell lung cancer (a type of lung cancer) that cannot be treated with surgery.
  • You have not received any previous treatment for your lung cancer, such as chemotherapy or radiation.
  • You are generally able to care for yourself (performance status 0-2).
  • Your liver, kidney, and blood test results are within acceptable limits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06109454Recruiting
Huaier granules after lung cancer surgery

This study tests whether Huaier granules can help prevent lung cancer from coming back after surgery. It is for people with stage II–IIIA non-small cell lung cancer who have recently had their tumor completely removed and have not had other treatments like chemotherapy or radiation.

Shenyang, Liaoning
NCT05860907Not yet recruiting· Phase 4
Huaier granules for advanced breast cancer without organ spread

This trial tests whether Huaier granules, a traditional Chinese medicine, can help people with advanced breast cancer that has not spread to major organs like the liver or lungs. You may join if you've had no more than one prior treatment and your cancer is not curable with surgery or radiation.

Shijiazhuang, Hebei
NCT06387368Not yet recruiting· Phase 4
Huaier granules with chemotherapy for advanced pancreatic cancer

This trial tests whether adding Huaier granules, a traditional Chinese medicine, to a chemotherapy pill called capecitabine helps people with pancreatic cancer that cannot be removed by surgery. You would take the granules by mouth along with the chemo, and researchers will see if this combination helps control the cancer and improves well-being.

NCT07741344Not yet recruiting· Phase 2
Comparing bronchoscopic microwave ablation and surgery for early-stage lung cancer

This study looks at two ways to treat early-stage lung cancer: using heat from a tiny probe passed through the airways to kill the tumor (microwave ablation), or surgery to remove the tumor and some surrounding tissue. The goal is to find which approach is more effective and safer for people with this type of lung cancer.

Hong Kong
NCT07528274Recruiting· Phase 2
Microwave ablation with immunotherapy for advanced lung cancer

This trial tests combining microwave ablation (heat treatment of tumors) with two drugs—tislelizumab (an immune-boosting drug) and docetaxel (chemotherapy)—for patients with advanced non-small cell lung cancer whose disease progressed after initial immunotherapy. The goal is to see if this combination can slow or shrink tumors better than standard treatment alone.

Tianjin, Tianjin Municipality
NCT06368063Recruiting· Phase 4
Huaier granules after pancreatic cancer surgery

This trial tests whether a Chinese herbal medicine called Huaier granules works better than standard chemotherapy for people with pancreatic cancer that was removed by surgery. Participants can choose to take Huaier granules or standard chemotherapy, and researchers will compare outcomes.

Xi'an, Shannxi

Hear when a new Microwave Ablation trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.